Drugs / Osteon II
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07186166 | Jan 2022 → Feb 2024 | — | Can Tho University of Medicine and Pharmacy | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Osteon II | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07186166 ↗ |
| Modality | Other / unclassified | “a synthetic bone substitute” PMID 42050510 ↗ Apr 2026 |